Tag Archives: Pfizer

Critics Say Biden Plan to Cut Drug Costs Too Friendly to Big Pharma

“Federal agencies have shown themselves reluctant to act against unreasonable prices, and this new proposal may give them permission to continue to do nothing,” said one expert.

By Brett Wilkins. Published 12-7-2023 by Common Dreams

Photo: ccPixs.com

While welcoming the White House’s willingness to tackle pharmaceutical companies’ patent abuse and high prescription drug prices, progressive critics argued Thursday that U.S. President Joe Biden must do more to challenge Big Pharma’s monopoly power.

The White House on Thursday announced “new actions to promote competition in healthcare and support lowering prescription drug costs for American families, including the release of a proposed framework for agencies on the exercise of march-in rights on taxpayer-funded drugs and other inventions.”

Continue reading
Share Button

‘For Shame’: Pfizer to Charge $1,390 for Lifesaving Covid Drug That Costs Just $13

“Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many,” said one consumer advocate.

By Brett Wilkins. Published 10-19-2023 by Common Dreams

Photo: Ministério da Saúde/flickr/CC

U.S. consumer watchdog Public Citizen on Thursday excoriated Pfizer after the pharmaceutical giant announced it would more than double the price of a lifesaving Covid-19 treatment, which will soon sell for an estimated 100 times the cost of production.

Pfizer said Wednesday that it will price its patented Covid treatment nirmatrelvir-ritonavir—sold under the brand name Paxlovid—at $1,390 for a five-day course. Researchers Melissa J. Barber and Dzintars Gotham recently estimated it costs Pfizer $13 to produce five days’ worth of the drug, which is taken in three-pill doses.

Continue reading
Share Button

‘Deeply Sinister’: Emails Reveal Big Pharma Pushed Twitter to Silence Vaccine Equity Voices

“At a time when online mobilizations were one of the few forms of protest available to the public, Twitter was seemingly asked to shield the powerful from criticism,” said one campaigner. “That should worry all those who care about accountability.”

By Brett Wilkins.  Published 1-16-2023 by Common Dreams

lobal Justice Now and The People’s Vaccine projection campaigning for global vaccine equality in London on March 8, 2021. (Photo: Jess Hurd/Global Justice Now via Flickr)

Drugmaker BioNTech and the German government pushed Twitter to “hide” posts by activists calling on Big Pharma to temporarily lift patents on Covid-19 vaccines—a move which would have given people the Global South greater access to the lifesaving inoculations, a report published Monday by The Intercept revealed.

Twitter lobbyist Nina Morschhaeuser “flagged the corporate accounts of Pfizer, BioNTech, Moderna, and AstraZeneca for her colleagues to monitor and shield from activists,” according to The Intercept‘s Lee Fang. An email from Morschhaeuser said the German Federal Office for Information Security also contacted Twitter on behalf of BioNTech, whose spokesperson, Jasmina Alatovic, asked the social media giant to “hide” activist tweets targeting her company’s account for two days. Continue reading

Share Button

Pharma Giants to Hike 350+ US Drug Prices in the New Year: Analysis

“Why? Because they can. Big Pharma does not care about us.”

By Brett Wilkins.  Published 12-30-2022 by Common Dreams

Photo: Images Money/flickr/CC

Global pharmaceutical giants plan to hike U.S. prices for hundreds of drugs next month in anticipation of the Biden administration’s Inflation Reduction Act, which will allow Medicare to negotiate the cost of certain drugs starting in 2026, an analysis published Friday revealed.

The analysis, conducted by the healthcare research company 3 Axis Advisors and reported on by Reuters, said that Big Pharma corporations including Pfizer, AstraZeneca PLC, and Sanofi SA are set to raise the list prices—which do not include any rebates—on over 350 drugs early in January. Continue reading

Share Button

‘Heartbreaking’ and ‘Pathetic’: US Obstructs Patent Waiver for Covid Tests and Treatments

“There have been at least 290,000 deaths from Covid-19 since the WTO punted on the question of global access to tests and treatments back in June,” said one advocate. “How many more need to die before the U.S. joins the right side of history?”

By Kenny Stancil.  Published 12-6-2022 by Common Dreams

Global health campaigners denounced U.S. President Joe Biden’s administration for refusing to support a temporary suspension of patents for Covid-19 tests and treatments this year, a move that further delays the possibility of securing a World Trade Organization intellectual property waiver aimed at increasing access to lifesaving medical tools in developing nations.

In a statement released on Tuesday morning, U.S. Trade Representative Katherine Tai said that “over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO members.” Continue reading

Share Button

Patients Push Biden HHS to Act as Pharma Firm Charges $190K for Lifesaving Prostate Cancer Drug

“HHS can clearly insist on limiting the U.S. price of Xtandi to the median price for other large high-income countries,” said advocates, “particularly since the drug has already generated more than $10 billion in sales from Medicare alone based upon these unconscionable pricing disparities.”

By Brett Wilkins  Published 11-20-2022 by Common Dreams

Screenshot: GlobalGiving

“Cancer does not wait, nor should cancer patients have to wait for years for their government to act.”

That’s the message patient advocates reiterated in a Friday letter asking the Biden administration to help them secure a lifesaving prostate cancer drug that costs nearly $190,000 per year despite its development being 100% taxpayer-funded.

Last year, prostate cancer patient Eric Sawyer petitioned U.S. Health and Human Services (HHS) Secretary Xavier Becerra to grant march-in rights—under which the government can grant patent licenses to companies other than a drug’s manufacturer—for enzalutamide, which is sold under the brand name Xtandi. Continue reading

Share Button

‘Daylight Robbery’: Pfizer Condemned for Hiking US Covid Vaccine Price by 10,000% Above Cost

“While health workers and the vulnerable continue to go unvaccinated in developing countries, Pfizer is shamelessly fleecing the public for ever-greater sums of money,” said one campaigner.

By Jake Johnson  Published 10-21-2022 by Common Dreams

Photo: U.S. Secretary of Defense/flickr

Vaccine equity campaigners on Friday condemned Pfizer for announcing that it will soon raise the price of its publicly funded Covid-19 shot to between $110 and $130 per dose in the U.S., a move that comes as the Biden administration is preparing to end the nation’s free coronavirus vaccine program as pandemic response funding runs dry.

Reuters reported late Thursday that Angela Lukin, an executive at Pfizer, said the New York-based pharmaceutical giant “expects” that the vaccine “will be made available at no cost to people who have private insurance or government-paid insurance.” Continue reading

Share Button

‘Terrible Idea’: Biden Preparing to Shift Costs of Covid Treatments, Vaccines to Patients

“We must push back,” said one doctor. “Free provision of vaccinations, Paxlovid, and monoclonals has been critically important.”

By Kenny Stancil  Published 8-19-2022 by Common Dreams

Army Spc. Angel Laureano holds a vial of the COVID-19 vaccine, Walter Reed National Military Medical Center, Bethesda, Md., Dec. 14, 2020. (DoD photo by Lisa Ferdinando)

Advocates for a more just healthcare system responded with alarm to Thursday reporting that the Biden administration is taking steps to stop paying for Covid-19 vaccines and treatments in the coming months, a move critics fear will lead to higher prices and more expensive coverage, enriching pharmaceutical and insurance giants at the expense of patients.

The U.S. Department of Health and Human Services (HHS) plans to meet with representatives from drug manufacturers, pharmacies, and state health departments on August 30 to “map out” how to shift the bill for coronavirus jabs and therapeutics from the federal government to individuals, according to The Wall Street Journal. Continue reading

Share Button

Unpatented Shot Dubbed ‘The World’s Covid-19 Vaccine’ Wins Emergency Approval in India

“This announcement is an important first step in vaccinating the world and halting the pandemic,” said Dr. Peter Hotez, a U.S.-based vaccine scientist.

By Jake Johnson.  Published 12-28-2021 by Common Dreams

Image; ZeeNews

An unpatented Covid-19 vaccine developed by the Texas Children’s Hospital, Baylor College of Medicine, and the pharmaceutical firm Biological E. Limited received emergency-use authorization from Indian regulators on Tuesday—news that the jab’s creators hailed as a potential turning point in the push to broaden global vaccine access.

“This announcement is an important first step in vaccinating the world and halting the pandemic,” Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor and co-director of the Texas Children’s Hospital Center for Vaccine Development, said in a statement. Continue reading

Share Button

‘Utterly Obscene’: Just 8 Pfizer and Moderna Investors Became $10 Billion Richer After Omicron Emerged

“Pharma execs and shareholders are making a killing from a crisis they helped to create,” said one justice campaigner.

By Jon Queally.  Published 12-5-2021 by Common Dreams

In the first week that the Omicron variant sparked global fears of a new wave of infections, a small handful of investors and executives with Pfizer and Moderna—currently the world’s preeminent makers of Covid-19 vaccines—saw over $10 billion in new wealth, with the Moderna’s CEO alone adding over $800 million to his personal fortune.

Based on data compiled by Global Justice Now and released Saturday, “just 8 top Pfizer and Moderna shareholders” added a combined $10.31 billion to their fortunes last week after stock prices soared in response to the emergence of Omicron. According to a statement by the group: Continue reading

Share Button